Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Talevi

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Current Topics in Medicinal Chemistry|August 3, 2018
Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?Juan F Morales, Lucas N Alberca, Sara Chuguransky, et al.
Journal of Chemical Information and Modeling|July 15, 2017
Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design StageMelisa E Gantner, Roxana N Peroni, Juan F Morales, et al.
Journal of Chemical Information and Modeling|July 27, 2021
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case StudyManuel A Llanos, Melisa E Gantner, Santiago Rodriguez, et al.
Journal of Chemical Information and Modeling|December 28, 2021
Tetracycline Derivatives Inhibit Plasmodial Cysteine Protease Falcipain-2 through Binding to a Distal Allosteric SiteJorge Enrique Hernández González, Lucas N Alberca, Yordanka Masforrol González, et al.
Current Computer-Aided Drug Design|June 28, 2012
An integrated drug development approach applying topological descriptorsAlan Talevi, Carolina L Bellera, Mauricio Di Ianni, et al.
Future Medicinal Chemistry|May 25, 2023
Synthesis and biological evaluation of new antiseizure compounds derived from valproic acidFederico M Garofalo, María L Sbaraglini, Emilia M Barrionuevo, et al.
Current Topics in Medicinal Chemistry|February 17, 2016
Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational OptionMaría Laura Sbaraglini, María Cristina Vanrell, Carolina Leticia Bellera, et al.
Journal of Chemical Information and Modeling|November 28, 2012
Several new diverse anticonvulsant agents discovered in a virtual screening campaign aimed at novel antiepileptic drugs to treat refractory epilepsyMauricio E Di Ianni, Andrea V Enrique, Pablo H Palestro, et al.
Frontiers in Chemistry|December 16, 2020
Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based NanocarriersGiuliana Muraca, Ignacio Rivero Berti, María L Sbaraglini, et al.
International Journal of Antimicrobial Agents|May 25, 2016
Novel cruzipain inhibitors for the chemotherapy of chronic Chagas diseaseMaría L Sbaraglini, Carolina L Bellera, Laura Fraccaroli, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Current Topics in Medicinal Chemistry|August 3, 2018
Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?Juan F Morales, Lucas N Alberca, Sara Chuguransky, et al.
Journal of Chemical Information and Modeling|July 15, 2017
Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design StageMelisa E Gantner, Roxana N Peroni, Juan F Morales, et al.
Journal of Chemical Information and Modeling|July 27, 2021
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case StudyManuel A Llanos, Melisa E Gantner, Santiago Rodriguez, et al.
Journal of Chemical Information and Modeling|December 28, 2021
Tetracycline Derivatives Inhibit Plasmodial Cysteine Protease Falcipain-2 through Binding to a Distal Allosteric SiteJorge Enrique Hernández González, Lucas N Alberca, Yordanka Masforrol González, et al.
Current Computer-Aided Drug Design|June 28, 2012
An integrated drug development approach applying topological descriptorsAlan Talevi, Carolina L Bellera, Mauricio Di Ianni, et al.
Future Medicinal Chemistry|May 25, 2023
Synthesis and biological evaluation of new antiseizure compounds derived from valproic acidFederico M Garofalo, María L Sbaraglini, Emilia M Barrionuevo, et al.
Current Topics in Medicinal Chemistry|February 17, 2016
Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational OptionMaría Laura Sbaraglini, María Cristina Vanrell, Carolina Leticia Bellera, et al.
Journal of Chemical Information and Modeling|November 28, 2012
Several new diverse anticonvulsant agents discovered in a virtual screening campaign aimed at novel antiepileptic drugs to treat refractory epilepsyMauricio E Di Ianni, Andrea V Enrique, Pablo H Palestro, et al.
Frontiers in Chemistry|December 16, 2020
Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based NanocarriersGiuliana Muraca, Ignacio Rivero Berti, María L Sbaraglini, et al.
International Journal of Antimicrobial Agents|May 25, 2016
Novel cruzipain inhibitors for the chemotherapy of chronic Chagas diseaseMaría L Sbaraglini, Carolina L Bellera, Laura Fraccaroli, et al.
Pageof 9